[go: up one dir, main page]

MA25917A1 - PROPIONIC ACID DERIVATIVES HAVING ACTIVATING PROPERTIES OF PPAR-ALPHA. - Google Patents

PROPIONIC ACID DERIVATIVES HAVING ACTIVATING PROPERTIES OF PPAR-ALPHA.

Info

Publication number
MA25917A1
MA25917A1 MA27091A MA27091A MA25917A1 MA 25917 A1 MA25917 A1 MA 25917A1 MA 27091 A MA27091 A MA 27091A MA 27091 A MA27091 A MA 27091A MA 25917 A1 MA25917 A1 MA 25917A1
Authority
MA
Morocco
Prior art keywords
ppar
alpha
propionic acid
acid derivatives
activating properties
Prior art date
Application number
MA27091A
Other languages
French (fr)
Inventor
Klaus Urbahns
Michael Woltering
Susanne Nikolic
Josef Pernerstorfer
Berthold Hinzen
Elke Dittrich-Wengenroth
Hilmar Bischoff
Claudia Hirth-Dietrich
Klemens Lustig
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10124905A external-priority patent/DE10124905A1/en
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MA25917A1 publication Critical patent/MA25917A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MA27091A 2000-10-05 2003-04-04 PROPIONIC ACID DERIVATIVES HAVING ACTIVATING PROPERTIES OF PPAR-ALPHA. MA25917A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10049208 2000-10-05
DE10124905A DE10124905A1 (en) 2000-10-05 2001-05-22 propionic acid derivatives

Publications (1)

Publication Number Publication Date
MA25917A1 true MA25917A1 (en) 2003-10-01

Family

ID=26007267

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27091A MA25917A1 (en) 2000-10-05 2003-04-04 PROPIONIC ACID DERIVATIVES HAVING ACTIVATING PROPERTIES OF PPAR-ALPHA.

Country Status (22)

Country Link
EP (1) EP1328508A2 (en)
JP (1) JP2004510757A (en)
CN (1) CN1479716A (en)
AU (1) AU2001293838A1 (en)
BG (1) BG107684A (en)
BR (1) BR0114437A (en)
CA (1) CA2424540A1 (en)
CZ (1) CZ2003964A3 (en)
EE (1) EE200300140A (en)
HN (1) HN2001000223A (en)
HR (1) HRP20030346A2 (en)
HU (1) HUP0302306A3 (en)
IL (1) IL155125A0 (en)
MA (1) MA25917A1 (en)
MX (1) MXPA03002901A (en)
NO (1) NO20031517L (en)
NZ (1) NZ525119A (en)
PL (1) PL361162A1 (en)
RU (1) RU2003112968A (en)
SK (1) SK4132003A3 (en)
UY (1) UY26951A1 (en)
WO (1) WO2002028821A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10151390A1 (en) * 2001-10-18 2003-05-08 Bayer Ag acetic acid derivatives
GB0214254D0 (en) * 2002-06-20 2002-07-31 Glaxo Group Ltd Chemical compounds
HRP20050336B1 (en) * 2002-10-21 2013-06-30 Janssen Pharmaceutica N.V. SUBSTITUTED TETRALINS AND INDANES AND THEIR APPLICATIONS
WO2004037778A1 (en) * 2002-10-21 2004-05-06 Janssen Pharmaceutica, N.V. Substituted tetralins and indanes
US20040171680A1 (en) * 2002-10-21 2004-09-02 Xiiaoli Chen Treating Syndrome X with substituted tetralins and indanes
EP1583754A1 (en) * 2003-01-06 2005-10-12 Eli Lilly And Company Thiophene derivative ppar modulators
KR101186386B1 (en) 2003-08-29 2012-09-26 오노 야꾸힝 고교 가부시키가이샤 Compound capable of binding s1p receptor and pharmaceutical use thereof
AR048931A1 (en) 2004-04-21 2006-06-14 Janssen Pharmaceutica Nv PROCESS FOR THE PREPARATION OF SUBSTITUTED AND INDIAN TETRALIN DERIVATIVES AND PREPARATION OF SYNTHESIS INTERMEDIARIES
CN100344618C (en) 2004-05-24 2007-10-24 北京摩力克科技有限公司 N-benzyl acryloyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
KR100699928B1 (en) 2004-10-05 2007-03-26 재단법인서울대학교산학협력재단 Method for preparing intermediates for the preparation of peroxysomal proliferator activated receptor alpha ligands
EP2371811B1 (en) 2004-12-13 2014-10-08 Ono Pharmaceutical Co., Ltd. Azetidinecarboxylic acid derivative and medicinal use thereof
CN101054372B (en) * 2006-04-11 2010-10-13 中国科学院上海药物研究所 Pyrimidine substituted benzenepropanoic acid derivative, its preparation method and use in curing polycystic kidney disease
EP2380884B1 (en) 2008-12-01 2014-02-12 Mitsubishi Tanabe Pharma Corporation Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof
JP5436941B2 (en) * 2009-06-03 2014-03-05 あすか製薬株式会社 Lactam compound or salt thereof and PPAR activator
UY34200A (en) 2011-07-21 2013-02-28 Bayer Ip Gmbh 3- (FLUOROVINIL) PIRAZOLES AND ITS USE
CN107406484A (en) * 2014-12-11 2017-11-28 中化帝斯曼制药有限公司荷兰公司 The method of acylated cyclic peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2320387A1 (en) * 1973-04-21 1974-10-31 Boehringer Mannheim Gmbh PHENOXYALKYLCARBONIC ACID DERIVATIVES AND METHOD FOR PREPARING THE SAME
GB9822473D0 (en) * 1998-10-16 1998-12-09 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CZ2003964A3 (en) 2003-08-13
HN2001000223A (en) 2001-10-25
CA2424540A1 (en) 2003-04-02
PL361162A1 (en) 2004-09-20
NO20031517D0 (en) 2003-04-03
RU2003112968A (en) 2004-09-20
NZ525119A (en) 2005-04-29
AU2001293838A1 (en) 2002-04-15
BR0114437A (en) 2003-07-01
EE200300140A (en) 2003-08-15
CN1479716A (en) 2004-03-03
SK4132003A3 (en) 2004-02-03
NO20031517L (en) 2003-05-28
BG107684A (en) 2003-10-31
WO2002028821A2 (en) 2002-04-11
HRP20030346A2 (en) 2005-04-30
HUP0302306A2 (en) 2003-10-28
HUP0302306A3 (en) 2005-02-28
UY26951A1 (en) 2002-06-20
IL155125A0 (en) 2003-10-31
EP1328508A2 (en) 2003-07-23
MXPA03002901A (en) 2003-10-15
JP2004510757A (en) 2004-04-08
WO2002028821A3 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
MA25917A1 (en) PROPIONIC ACID DERIVATIVES HAVING ACTIVATING PROPERTIES OF PPAR-ALPHA.
MA25875A1 (en) NOVEL DERIVATIVES OF AMINODICARBOXYLIC ACID HAVING PHARMACEUTICAL PROPERTIES.
FR20C1039I2 (en) DERIVATIVES OF UK-2A
MA26932A1 (en) DERIVATIVES OF IMIDAZOLE.
FR15C0086I2 (en) HYDROXAMATE DERIVATIVES AS DESACETYLASE INHIBITORS
MA26812A1 (en) PYRIMIDINE-2,4,6-TRIONES INHIBITORS OF METALLOPROTEINASES
EP1494676A4 (en) FOLLOQUINATED QUINOLAXIN DERIVATIVES AS INHIBITORS OF AKT ACTIVITY
IS6448A (en) Bacterial properties of 3-amonoquinazole-2.4dione
EP1620095A4 (en) INHIBITORS OF AKT ACTIVITY
EP1496896A4 (en) INHIBITORS OF AKT ACTIVITY
EP1496906A4 (en) INHIBITORS OF AKT ACTIVITY
AU2002236683A1 (en) Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates
AU2002232439A1 (en) Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
MXPA03004794A (en) New mandelic acid derivatives and their use as throbin inhibitors.
MA27083A1 (en) NICOTINE OR ISONICOTINE BENZOTHIAZOLE DERIVATIVES
SI1337521T1 (en) Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
PT1177195E (en) 1-AMINO-TRIAZOLO¬4,3-A | QUINAZOLIN-5-ONES AND / OR -5-THIONS INHIBITORS OF PHOSPHODIESTERASES IV
AU2002364044A1 (en) Ultrasound sensing of concentration of methanol's aqueous solution
FR2813084B1 (en) PREPARATION OF LACTIC ACID BACTERIA WITH BIOPURIFICATION ACTIVITY
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
MXPA03004303A (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain.
AU2001235437A1 (en) Isothiazolecarboxylic acid derivatives and their use as microbicides
ITRM20020629A1 (en) USE OF ALPHA-PHENYLTHIOCARBOXYL AND ACHYLPHOXYCARBOXYLIC ACIDS WITH HYPOGLYCEMY AND / OR HYPOLIPIDEMIZING ACTIVITY.
EE200200511A (en) Hydroxyphenylpiperazinylmethylbenzamide derivatives for the treatment of pain
AR028607A1 (en) DERIVATIVES OF 1,4-DIAZEPAN-2,5-DIONA